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Abstract
The arcuate nucleus of the hypothalamus is a primary site for sensing blood borne nutrients and hormonal
messengers that reflect caloric status. To identify novel energy homeostatic genes, we examined RNA
extracts from the microdissected arcuate nucleus of fed and 48-h fasted rats using oligonucleotide mic-
roarrays. The relative abundance of 118 mRNA transcripts was increased and 203 mRNA transcripts was
decreased during fasting. One of the down-regulated mRNAs was ankyrin-repeat and suppressor of
cytokine signalling box-containing protein 4 (Asb-4). The predicted structure of Asb-4 protein suggested
that it might encode an intracellular regulatory protein, and therefore its mRNA expression was investigated
further. Reverse transcription quantitative polymerase chain reaction was used to validate down-regulation
of Asb-4 mRNA in the arcuate nucleus of the fasted Sprague-Dawley rat (relative expression of Asb-4
mRNA: fed ¼ 4.66 ± 0.26; fasted ¼ 3.96 ± 0.23; n ¼ 4, P < 0.01). Down-regulation was also demon-
strated in the obese fa/fa Zucker rat, another model of energy disequilibrium (relative expression of Asb-4
mRNA: lean Zucker ¼ 3.91 ± 0.32; fa/fa ¼ 2.93 ± 0.26; n ¼ 5, P < 0.001). In situ hybridisation shows that
Asb-4 mRNA is expressed in brain areas linked to energy homeostasis, including the arcuate nucleus,
paraventricular nucleus, dorsomedial nucleus, lateral hypothalamus and posterodorsal medial amygdaloid
area. Double in situ hybridisation revealed that Asb-4 mRNA colocalises with key energy homeostatic
neurones. In the fed state, Asb-4 mRNA is expressed by 95.6% of pro-opiomelanocortin (POMC) neurones
and 46.4% of neuropeptide Y (NPY) neurones. By contrast, in the fasted state, the percentage of POMC
neurones expressing Asb-4 mRNA drops to 73.2% (P < 0.001). Moreover, the density of Asb-4 mRNA per
fasted POMC neurone is markedly decreased. Conversely, expression of Asb-4 mRNA by NPY neurones in
the fasted state is modestly increased to 52.7% (P < 0.05). Based on its differential expression, neuroan-
atomical distribution and colocalisation, we hypothesise that Asb-4 is a gene involved in energy home-
ostasis.
Tremendous advances have been made in identifying the
molecular signals and neuroanatomical pathways that regu-
late body weight. Research has established that leptin, insulin,
ghrelin, peptide YY3-36 and cholecystokinin, and nutrients
such as glucose and fatty acids, are key peripheral messen-
gers, which communicate energy status to central nervous
system (CNS) centres involved in energy homeostasis (1–3).
In addition, there is evidence that two preproglucagon
derivatives, glucagon-like peptide 1 (4–6) and oxyntomodulin
(7, 8), and pancreatic polypeptide (9–12) are physiologically
relevant peripheral nutrient messengers. A number of other
peptides and metabolic products may also partake in this
process (13). Notably, with the exception of ghrelin, which is
orexigenic (appetite-stimulating), these mediators are ano-
rexigenic (satiety-inducing) and provide negative feedback.
Insulin, leptin and peptide YY3-36, and presumably gluca-
gon-like peptide 1, oxymodulin and pancreatic polypeptide,
enter the CNS across permeable areas in the blood–brain
barrier and reach target neurones in the arcuate nucleus of the
hypothalamus and dorsal vagal complex of the brainstem (1,
14). Cholecystokinin and ghrelin transmit their messages
through vagal afferents (15).
Inasmuch as arcuate nucleus and dorsal vagal complex
neurones are the first CNS neurones to receive peripheral
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nutrient signals, they can be regarded as first order sensory
neurones in the homeostatic process (1, 14). After sensing and
integrating peripheral and central signals, these first order
neurones communicate with second order effector neurones.
Afferent projections to the arcuate nucleus from numerous
brain regions undoubtedly contribute to this process (16, 17).
The cytoarchitecture of the arcuate nucleus is consonant
with its first line status in energy homeostasis. Over the past
decade, physiological (18–20), neuroanatomical (21–31) and
gene targeting studies (32–34) have identified two physiolog-
ically opposing populations of arcuate nucleus neurones,
which are crucial to energy homeostasis. The first population
is located predominantly in the ventromedial arcuate nucleus
and coexpress the orexigenic neuropeptides neuropeptide Y
(NPY) and agouti-related protein (AGRP). The second
population is located predominantly in the ventrolateral
arcuate nucleus and coexpress anorexigenic neuropeptides
derived from the pro-opiomelanocortin (POMC) prohor-
mone [e.g. a- and c-melanocyte stimulating hormones
(MSH)] and the cocaine- and amphetamine-regulated tran-
script (CART). This is a remarkable functional organisation
from the perspective that AGRP is a competitive antagonist
of a- and c-MSH at two key brain receptors involved in
energy balance, namely the melanocortin-3 and -4 receptors
(33, 35–39).
Despite this wealth of knowledge about arcuate nucleus
physiology, it is likely that key regulatory genes involved in
energy homeostasis remain unidentified. To identify such
genes, we performed gene chip array studies on the micro-
dissected arcuate nucleus. In the present study, we provide a
list of candidate arcuate nucleus energy homeostatic genes
whose mRNAs are regulated by fasting, and discuss in detail
a gene previously annotated according to its two structural
domains, ankyrin-repeat and suppressor of cytokine signal-
ling box-containing protein 4 (Asb-4). Because these predicted
structural motifs suggested to us that Asb-4 might encode an
intracellular protein that binds and regulates the function of
other energy homeostatic proteins, the gene was selected for
more detailed examination.
Materials and methods
Animals and experimental protocol
Seven-week-old male Sprague-Dawley rats (Harlan Laboratories, Madison,
WI, USA) (weighing 280–300 g) were used for microarray studies. Rats within
a treatment group were housed in the same cage under conditions that are in
accordance with the University of Michigan Unit of Laboratory Animal
Medicine guidelines. Animals were maintained at 22±2 C in a room under a
12 : 12 h light/dark cycle. The University Committee on Use and Care of
Animals approved all animal experiments. The experiment was repeated five
times. For each of the five experiments, four rats were included in the fed
group and four rats in the fasted group. Therefore, a total of 20 fed and 20
fasted rats were eventually used to obtain five separate paired RNA samples.
Animals in the fed group were allowed free access to regular rat chow and
water throughout the 48-h time course of the experiments. Animals in fasted
group were food deprived for the 48-h time course of the experiments but were
allowed free access to water. Experiments were initiated at 10.00 h and all
dissections were performed between 10.00 h and 11.00 h. At the end of the
48-h period, animals were sequentially euthanised by decapitation and their
brains rapidly dissected. Brains were imbedded in powderised dry ice. A 1 mm
acrylic coronal brain matrix (Braintree Scientific, Inc., Kingston, MA, USA)
was used for sectioning. Rostrally, a coronal cut was made immediately
posterior to the optic chiasm and a second coronal cut was made 2 mm caudal
to the first. The 2-mm block of brain was used for microdissection. Brain
sections were placed on dry ice and under 4· magnification a Stoelting 0.77-
mm brain punch was used to obtain arcuate nucleus tissue. Punches were
made bilaterally adjacent to the third ventricle above the median eminence.
Because the punch is circular, small portions of the arcuate nucleus could have
been excluded and small amounts of tissue from adjacent nuclei included.
Tissue from each group was pooled for RNA extraction using a Dounce
homogeniser and TRIzol Reagent (Life Technologies, Rockville, MD, USA).
After the 75% ethanol wash step in the TRIzol extraction procedure, RNA
from pooled arcuate nucleus was dissolved in water. An additional cleanup
step was then performed using the Qiagen RNeasy Mini Kit per manufac-
turers instructions (Qiagen, Valencia, CA, USA).
5 lg of total RNA was converted into double-stranded cDNA using a
Superscript Choice System for cDNA synthesis (Invitrogen, Carlsbad, CA,
USA) with an oligo (dT) 24 primer containing a T7 RNA polymerase
promoter at its 3¢ end (Genset, La Jolla, CA, USA). Following second strand
synthesis, labelled cRNA was generated from the cDNA sample by an in vitro
transcription reaction supplemented with biotin-11-CTP and biotin-16-UTP
(BioArray High Yield RNA Transcript Labeling Kit, Enzo, Farmingdale,
NY, USA). The labelled cRNA was purified using a Qiagen RNeasy spin
column (Qiagen). 15 lg of each cRNA was fragmented at 94 C for 35 min in
fragmentation buffer (40 mM Tris-acetate (pH 8.1), 100 mM potassium
acetate, 30 mM magnesium acetate) and then used to prepare 300 ll of
hybridisation cocktail [100 mM 2-(morpholino)ethanesulphonic acid, 1 M
NaCl, 20 mM EDTA, 0.01% Tween 20] containing 0.1 mg/ml of herring
sperm DNA, 500 lg/ml acetylated bovine serum albumin and a mixture of
control cRNAs (BioB, BioC, BioD and Cre) for comparison of hybridisation
efficiency between arrays and for relative quantification of measured
transcript levels. Before hybridisation, the cocktails were heated to 94 C
for 5 min, equilibrated at 45 C for 5 min, then clarified by centrifugation
(16 000 g) at room temperature for 5 min. Aliquots of each sample (10 lg of
fragmented cRNA in 200 ll of hybridisation cocktail) were hybridised to the
Affymetrix Rat Expression Set 230 A and B arrays (Affymetrix, Santa Clara,
CA, USA) at 45 C for 16 h in a rotisserie oven set at 60 r.p.m. The arrays
were then washed with nonstringent wash buffer (6 · SSPE) at 25 C,
followed by a stringent wash buffer [100 mM 2-(morpholino)ethanesulphonic
acid (pH 6.7), 0.1 M NaCl, 0.01% Tween 20] at 50 C, stained with
streptavidin-phycoerythrin (Molecular Probes, Eugene, OR, USA), washed
again with 6 · SSPE, stained with biotinylated antistreptavidin IgG, followed
by a second staining with streptavidin-phycoerythrin, and a third washing
with 6 · SSPE. Rat 230 A and 230B arrays have 31 042 probe-sets
representing 28 757 genes and 30 248 transcripts.
Microarray analysis
Microarrays were scanned and probe intensities obtained with software from
Affymetrix (Microarray Suite 5.0). Default analysis to obtain probe-set
intensities as well as present calls were obtained from the Affymetrix software.
We also used our own publicly available software (http://www.dot.ped.
med.umich.edu:2000/pub/arc/index.html) to obtain probe-set intensities and
normalise them, as described below. Rat expression set 230 A and 230B arrays
were processed separately, using the first fed sample as the standard in each
case. Each probe-set on the arrays typically consists of 11 25-base oligonu-
cleotides complementary to a specific cDNA, which are called perfect match
(PM) features, and 11 mismatch (MM) probes that are identical to the PM
probes, except that the central base has been altered. Probe-pairs with PM-
MM <)100 on the standard were removed from the analysis. One-sided
signed-rank tests of PM-MM >0 were performed for each probe-set on each
array, and P < 0.01 was used to judge that the associate transcript was
detectable. For each array, the largest and smallest 20% of the PM-MM
differences for a probe-set were discarded and the remaining differences
averaged to obtain (unnormalised) probe-set intensities. The standard 230 A
array was scaled (every value multiplied by a constant) to provide an average
of 1500 U, and the remaining A arrays normalised to the standard using a
piecewise linear function that made 99 evenly spaced quantiles agree with the
quantiles of the standard. We scaled the standard 230B array by using data for
nine probe-sets that are identical on the A and B arrays for the standard
sample, making the geometric mean of the ratios for these probe-sets equal
1.0. This resulted in the B array standard providing an average over all probe-
sets of 445 U. The remaining B arrays were then normalised to the standard B
array using the same quantile-normalisation algorithm as used for the A
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arrays. The normalised data were log-transformed using log[-
max(x + 50,0) + 50] to perform paired t-tests between fasting and fed
samples. Fold-change indices for each pair of samples were obtained by
forming the ratio of normalised intensities, except that intensities smaller than
50 U were replaced by 50. An overall fold-change was computed as the
geometric mean of these five individual fold-changes.
To estimate the false positive rate for this selection, we performed the same
selection on data sets for which the labels for pairs of fasting and fed samples
were permuted in every possible combination that differed from the actual
labels. Information about genes was obtained using the National Center for
Biotechnology Information (NCBI) database interfaces to LocusLink, Uni-
Gene, and HomoloGene, as well as Medline.
Reverse transcription quantitative polymerase chain reaction (RT-QPCR)
RT-QPCR was performed using a BioRad iCycler iQ Real Time PCR
Detection System (BioRad Laboratory, Inc., Carlsbad, CA, USA) and FAM-
labelled fluorogenic probes. RT-QPCR was performed using the SuperScript
One-Step RT-PCR System with Platinum Taq DNA Polymerase (Invitrogen).
10 ng of arcuate nucleus total RNA, gene specific primers and probes were
added to each reaction mixture. PCR conditions were RT (48 C, 30 min)
followed by PCR amplification (one cycle at 95 C for 5 min followed by 60
cycles of 95 C for 30 s; 60 C for 30 s; 72 C for 30 s). Triplicate wells were
run for each sample. Relative mRNA expression was normalised to GAPDH.
Cloning of the rat Asb-4 cDNA
TheAffymetrix probe-set information annotatedAsb-4mRNAas a transcribed
sequence corresponding to UniGene cluster Rn.16079. A BLAST search of the
NCBInucleotide database using theRn.16079 target sequence identified it as the
rat homolog of the mouse Asb-4 cDNA (GenBank accession no. BC056440). A
further BLAST search using the mouse Asb-4 sequence as the query sequence
identified a rat BAC clone CH230-252C14 (GenBank accession no. AC109666).
Themouse and humanAsb-4 genes are known to have five exonswith conserved
intron/exon boundaries (40). Comparison of the rat genomic sequence with the
mouse sequences revealed that five exons were also present in the rat gene. To
generate a rat Asb-4 cDNA, we designed PCR primers according to the
sequences of the predicted 5¢ start and 3¢ stop codons. Each of the primers
contained a small amount of 5¢- and 3¢UTR.The sense primerwas 5¢-CCCAAG
CTT AGG GCT CGG AGG ATG GAC GGC ATC-3¢. The antisense primer
was 5¢-CGGAATTCTGCGTCTACCCAGTGAGTCCACTTAG-3¢. The
PCR was performed using cDNA generated from microdissected arcuate
nucleus total RNA. PCR was performed using TITANIUM TagDNA
polymerase plus TagStart antibody (Advantage 2 Enzyme Kit, Invitrogen)
and a Perkin-Elmer 480 thermal cycler (Perkin-Elmer, Boston, MA, USA)
programmed for one cycle at 95 C for 2 min followed by 35 cycles at 95 C for
15 s; 60 C for 30 s; and 68 C for 90 s.
In situ hybridisation
A 568-bp PCR generated fragment of the rat Asb-4 cDNA (codon 681–1248)
was subcloned into pBluescript SK (Stratagene, La Jolla, CA, USA) for in situ
hybridisation. The sense primer was: 5¢-CGG GAT CCG GAG CAG GAG
TAC AGC AGG GAA CA-3¢. The antisense primer was 5¢-CGG AAT TCT
GAC AGT GGG AGG GAC AGC ATA GG-3¢. The NPY cDNA
(AI045437) in pT7T3D-PAC was purchased from Invitrogen. The rat POMC
plasmid construct consisted of an 833-bp insert that included the full coding
region of the POMC gene inserted into pGEM4Z (Promega, Madison, WI,
USA). The POMC-pGEM4Z plasmid was constructed by R. C. Thompson.
Seven-week-old male Sprague-Dawley rats (weighing 280–300 g) were
anaesthetised with ketamine/xylazine and perfused via the ascending aorta
with 200 ml of phosphate buffered saline (PBS), followed by 200 ml of 4%
paraformaldehyde in PBS. The brain was postfixed for 16 h then transferred
to 20% sucrose (20% sucrose in PBS with 0.02% sodium azide) for 5 days at
4 C. The brain was embedded with 20% sucrose and Tissue-Tek OCT (2 : 1)
and coronal sections of 14 lm were cut on a cryostat. The sections were dried
overnight at room temperature and were stored at )80 C until further
processing. Sections studied covered the telencephalon and diencephlon from
coordinates bregma )0.80 mm to bregma )4.16 mm according to Paxinos and
Watson (41).
In situ hybridisation was conducted using a modification of a previously
described technique (42, 43). The brain sections were washed three times with
2 · SSC and then digested with 0.45 lg/ml proteinase K (Invitrogen) in
100 mM Tris, pH 8.0, 50 mM EDTA) for 15 min at 37 C. After brief washing
with distilled water, the sections were acetylated with 0.25% acetic anhydride
in 0.1 M triethanolamine (pH 8.0) for 10 min. The sections were subsequently
dehydrated through a graded series of ethanols.
The 35S-labelled antisense and sense Asb-4 RNA probes, Dig-labelled
antisense and sense NPY and POMC RNA probes were generated using
standard in vitro transcription methodology (44). Antisense or sense probes
(negative control) were diluted in hybridisation buffer (50% formamide,
3 · SSC, 1 · Denhart’s, 200 lg/ml yeast tRNA, 50 mM phosphate buffer,
pH 7.4, 10% dextran sulphate and 10 mM DTT) to yield approximately
1.2 · 106 c.p.m./40 ll. 40 ll diluted probes were applied to each slide and the
sections coverslipped. Slides were then placed in sealed plastic boxes lined with
filter paper moistened with 50% formamide. These boxes were wrapped with
plastic wrap and incubated at 55 C for 16 h.
For single label in situ hybridisation, the sections were hybridised with
antisense 35S-labelled Asb-4 riboprobe. For dual label in situ hybridisation,
the sections were hybridised with antisense digoxigenin (DIG)-labelled NPY
or POMC and Asb-4 35S-labelled riboprobes.
Following overnight incubation, coverslips were removed by dipping in
2 · SSC and the slides were washed with 2 · SSC. Slides were then incubated
with 200 lg/ml RNase A (Roche, Indianapolis, IN, USA) in 10 mM Tris-HCl,
pH 8.0, 0.5 M NaCl at 37 C for 1 h. The slides were washed with 2 ·, 1 ·,
0.5 · and 0.1 · SSC at room temperature and then incubated in 0.1 · SSC at
67 C for 1 h. The sections were washed briefly with distilled water. For single
label in situ hybridisation, the slides were dehydrated in graded alcohols and
air-dried. Dried slides were exposed to Kodak BioMax film (Kodak,
Rochester, NY, USA). For dark-field photomicrographs, cells were dipped
in Ilford K.5D nuclear emulsion (Ilford Imaging, Mobberley, UK).
For dual label in situ hybridisation, after washing with distilled water, the
sections were incubated with anti-DIG antibody (Roche) conjugated with
alkaline phosphatase (dilution 1 : 20 000) overnight at room temperature. The
slides were next incubated in nitroblue terazolium chloride and 5-bromo-4-
chloro-3-indolyl-phosphate solution for 2–4 h and then dipped in Ilford K.5D
nuclear emulsion. Sections were developed with D-19 developer. For NPY
and POMC colocalisation studies, six fed and six fasted rats were used. For
each rat, eight brain sections representing the rostral, middle and caudal
portions of the ARC were counted.
Virtual Northern
Virtual Northern Blots (45) were performed using the Smart PCR cDNA
Synthesis Kit (Clontech, Palo Alto, CA, USA).
Results
Microarray analysis
Because of the difficulty of reliably finding differences for
low-abundance transcripts, we obtained datasets from analy-
sis using Affymetrix software, as well as our own, hoping to
improve the robustness of our selection. We first made a
preliminary selection that removed all probe-sets for which
eight or more of the 10 samples gave an absent call according
to Affymetrix’s test for the presence of a transcript, or had
eight or more samples giving P > 0.01 for our own similar
test. This left 16 695 probe-sets (10 164 on the A array, 6531
on the B array). We further required that P < 0.05 for a
paired T-test between fasting and fed samples on our log-
transformed data, as well as that the average fold-change for
the five pairs, be larger than 1.2 (in either direction). This
selected 395 probe-sets. A fold-change of greater than or less
than 1.2 was chosen based on our previous studies, which also
showed small fold changes and indicated that signature
mRNAs, such as POMC, NPY and CART, were included by
this criterion (46). Finally, we asked that the fold-change
estimates in our data, as well as differences in the Affymetrix
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dataset, both had at least four out of the five pairs changing in
the same direction, which left 326 probe-sets (230 on array A,
and 96 on array B). Because three genes had two probe-sets
and one had three, a total of 321 genes were represented by
the 326 probe-sets. Spread sheets containing the 326 probe-
sets and a list of the entire 31 256 probe-sets examined, as well
as the .CEL level data (probe cell data that can be used by the
public for additional analysis), are available as supplementary
material to this paper.
Permutation testing on the 326 probe-sets (230 on the A
chip and 96 on the B chip) obtained an average of 45.4 probe-
sets from the permuted data sets for the A arrays, and 37.0
probe-sets for the B arrays. We thus estimate that 19.7% of
the 230 selected probe-sets on the A arrays are false-positives,
and that 38.5% of the 96 selected probe-sets on the B arrays
are false-positives. The overall estimated false discovery rate
was 25.3% for the total set of 326 selected probe-sets.
If 16 695 is used as a measure of genes expressed in the
arcuate nucleus, then 16 695/31 256 or 53.4% of probe-sets
are expressed in the arcuate nucleus. The number of genes
would be somewhat lower because of multiple probe-sets for
a single gene.
Asb-4 (Rn.16079) is categorised under Other Proteins (see
Supplementary material). It has two probe-sets. The degree of
Asb-4 mRNA down-regulation detected by microarray was
)1.31 and )1.34, which is a greater reduction than that of
CART ()1.21), a satiety factor known to be down-regulated
with fasting (47).
Reverse transcription quantitative PCR and virtual Northern
Table 1 lists results of genes that were validated by RT-
QPCR or virtual Northern. Down-regulation of Asb-4
mRNA in the arcuate nucleus of fasted rats was confirmed
(relative expression of Asb-4: fed ¼ 4.66 ± 0.26; fas-
t ¼ 3.96 ± 0.23; n ¼ 4, P < 0.01). To investigate Asb-4
mRNA expression in a second model of energy disequili-
brium, we examined the genetically obese Zucker rat (fa/fa).
Compared to the lean Zucker rat, Asb-4 mRNA was down-
regulated in the arcuate nucleus of the fa/fa rat (Asb-4:
lean ¼ 3.91 ± 0.32; fa/fa ¼ 2.93 ± 0.26; n ¼ 5; P < 0.001).
Cloning of the rat Asb-4 cDNA
The size of the coding region of the rat Asb-4 cDNA is
1281 bp. The rat Asb-4 cDNA sequence was deposited into
GenBank (accession number AY577765). There is 94%
nucleotide identity between the rat and mouse sequences in
the Asb-4 coding region. The PCR product was a single band
on 1% agarose gel electrophoresis. It was subcloned into
pcDNA3.1 (Invitrogen) and its sequence confirmed by DNA
sequencing. The presence of a single band on agarose gel
electrophoresis indicates that a shorter splice variant of Asb-4
(GenBank accession number NM_145872) is not present in
the arcuate nucleus because this shorter variant would have
been generated by our PCR primers (primer sequences
presented in the Methods section) and detected as a second
band in the gel 231 bp smaller in size.
In situ hybridisation
Figure 1 shows photomicrographs of the neuroanatomical
distribution of Asb-4 mRNA in the hypothalamus and
amygdala from rostral (Fig. 1A) to caudal (Fig. 1C). Fig-
ure 1(A) corresponds approximately to Fig. 26 in Paxanos
and Watson (41). Figure 1(B,C) corresponds approximately to
Figs 29 and 30 and Fig. 32 of Paxanos and Watson (41),
respectively. Asb-4 mRNA was detected in the arcuate
nucleus (ARC), paraventricular nucleus (PVN), periventri-
cular nucleus (Pe), dorsomedial nucleus (DMN), lateral
hypothalamus and posterior hypothalamus. In the amygdala
Asb-4 mRNA was observed in an area that included the
posterodorsal part of the medial amygdaloid nucleus (MePD)
and the intra-amygdaloid division of the bed nucleus of the
stria terminalis (BSTIA). No specific hybridisation above
background occurred when sense probe was used (Fig. 1D).
Figure 2 shows photomicrographs of the neuroanatomical
distribution of Asb-4 mRNA using dark field microscopy.
Table 1. Genes Validated by Reverse Transcription Quantitative Polymerase Chain Reaction (RT-QPCR) to be Up or Down-








Asb-4 0.75 0.003 0.85 0.002 0.75 0.007
Stearoyl CoA desaturase 1 0.57 0.004 0.64 0.043 0.88 0.045
Acetyl CoA synthetase 1 0.75 0.004 0.84 0.005 0.86 0.08
HMG CoA synthase 2 1.82 0.003 1.93 0.02 0.87 0.057
Fatty acid binding protein 7 0.62 0.0016 0.62 0.012 0.54 0.03
Insulin-like growth factor II 0.57 0.015 0.67 0.042 0.73 0.027
Insulin-like growth
factor binding protein 5
0.63 0.00005 0.51 0.004 0.54 0.002
Neuromedin B 1.89 0.003 3.0 0.016 2.01 0.035
C-Kit receptor 0.68 0.007 0.75 0.044 0.46 0.03
Kruppel-like factor 9 1.48 0.004 1.27 0.02 0.9 0.4
AW435415, EST 1.75 0.002 1.74 0.001 1.23 0.144
Prostaglandin D synthase 0.47 0.03 0.77 0.047 0.68 0.015
SGK 1.84 0.0008 1.99a 0.008 1.42a 0.0319
Tpra40 1.23 0.027 1.02 0.6 —
aVirtual Northern blot.
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Asb-4 mRNA is demonstrated in the paraventricular nucleus
(PVN, Fig. 2A), dorsomedial nucleus (DMN, Fig. 2B), lateral
hypothalamus (Fig. 2C) and amygdala (Fig. 2D). Within the
PVN, Asb-4 mRNA was observed in the parvicellular
portion. The broken line outlines the boundaries of the PVN.
Figure 3 shows dark field photomicrographs of Asb-4
mRNA in the rostral and mid-portions of the arcuate nucleus
of fed and fasted rats. Figure 3(A,B) is representative coronal
sections of the rostral arcuate nucleus in the fed and fasted
states, respectively. A marked down-regulation in Asb-4
mRNA occurs in the rostral arcuate nucleus in the fasted
state. A smaller degree of down-regulation is observed in the
mid-portion of the arcuate nucleus (Fig. 3C,D). Of note,
lateral cellular elements in Fig. 3(C,D) show a greater change
than medial elements. This is compatible with the known
POMC neurone localisation, which is predominantly in the
lateral arcuate nucleus.
Figure 4 shows photomicrographs of double in situ hy-
bridisations in the arcuate nucleus. Blue represents digoxige-
nin labelled POMC neurones (Fig. 4A,B) and NPY neurones
(Fig. 4C,D). Arrows indicate double labelled neurones.
Figure 4(A) is representative of the fed rat. Dense clustering
of silver grains, which represent Asb-4 mRNA, is present over
POMC neurones in the fed state. Figure 4(B) is representative
of the fasted rat. The density of silver grains is markedly
lower over POMC neurones, indicating much less expression
of Asb-4 mRNA per POMC neurone in the fasted state.
Figure 4(C,D) shows NPY neurones in the fed and fasted
states. Compared to POMC neurones, NPY neurones have
much fewer silver grains in the fed state (Fig. 4C). A small,
but statistically significant increase in NPY neurone Asb-4
mRNA expression was observed in fasted rats (Fig. 4D).
In the fed state, 95.6 ± 0.5% of POMC neurones and
46.4 ± 1.6% of NPY neurones express Asb-4 mRNA. In the
fasted rat, the number of POMC neurones expressing Asb-4
mRNA drops to 73.2 ± 2.2% (P < 0.001). The number of
NPY neurones expressing Asb-4 mRNA in the fasted state
was modestly increased to 52.7 ± 1.9% (P < 0.05).
Co-localisation was defined as the presence of silver grains

















Fig. 1. Photographs showing the neuroanatomical distribution of Asb-4 mRNA. PVN, Paraventricular nucleus; ARC, arcuate nucleus; DMN, dorsomedial
nucleus; Pe, periventricular nucleus; LH, lateral hypothalamic area; BSTIA, bed nucleus of the stria terminalis, intra-amygdaloid division; MePD, medial
amygdaloid nucleus, postero-dorsal part. Scale bar ¼ 1.0 mm.
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Discussion
The arcuate nucleus is believed to sense and integrate blood
borne and afferent central nervous system signals that are
indices of nutrient balance. Our experiment explores the
transcriptome that subserves those functions.
Our list of candidate arcuate nucleus energy homeostatic
genes contains many familiar in arcuate nucleus physiology
including NPY, CART, suppressor of cytokine signalling-3
(48), signal transducer and activator of transcription-3 (49)
and insulin receptor substrate-1 (50) (see Supplementary
material). The list also drew our attention to proteins less
well known for their association with feeding behaviour,
including insulin-like growth factor II (51), neuromedin B
(52), neurotensin (53), diazepam binding inhibitor (the
precursor of octadecaneuropeptide) (54) and growth hor-
mone releasing hormone (55). Our list also identifies a well
developed pathway for lipid metabolism. This is of potential
significance because monounsaturated long chain fatty acids
such as oleic acid are potent anorexigens (56). Interestingly,
stearoyl-CoA desaturase-1, one of the down-regulated
mRNAs, is a key enzyme in the production of monoun-
saturated long chain fatty acids such as oleic acid and has
previously been shown to be a leptin-regulated gene (57).
Notably, another regulated mRNA, fatty acid binding
protein-7 prefers C:18 monounsaturated fatty acids such as
oleic acid (58). Modulation of long chain fatty acid levels
locally in the arcuate nucleus may be an important
component of energy homeostasis. Adenylate monophos-
phate-activated kinase has recently been identified as a
monitor of cellular energy stores in the hypothalamus (59).
The alpha 1 catalytic and gamma 2 non-catalytic subunits of
the adenylate monophosphate-activated kinase were identi-
fied as oppositely regulated mRNAs in this study. Tran-
scripts chosen for validation to date are listed in Table 1.
Concordance of RT-QPCR results between the 48-h fasted
rat and the genetically obese fa/fa rat was common but
not universal. We viewed the fa/fa rat as second model of
energy disequilibrium and interpreted concordance as an
additional piece of evidence implicating a transcript in














Fig. 2. Dark field photomicrograph showing Asb-4 mRNA in the (A) PVN, paraventricular nucleus; PaMp, paraventricular nucleus medial parvocellular part;
PaLM, paraventricular nucleus lateral magnocellular part; the broken line outlines the periphery of the PVN and shows that Asb-4 mRNA is not expressed in
magnocellular neurones; 3V, third ventricle; (B) DMN, dorsomedial nucleus; (C) LH, lateral hypothalamus; (D) MePD, medial amigdaloid nucleus, postero-
dorsal part; BSTIA, bed nucleus of the stria terminalis, intra-amygdaloid division; opt, optic tract. Scale bar ¼ 500 lm.
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Asb-4 was chosen from among our list of candidate genes
for more detailed study because of its unique structural
features. Based on existing knowledge of the functions of
ankyrin repeats and suppressor of cytokine signalling (SOCS)
boxes (see below), we hypothesised that Asb-4 might have a
novel role in the intracellular regulation of energy home-
ostasis. Our neuroanatomical data support this proposed
function. NPY/AGRP and POMC/CART neurones are
central to arcuate nucleus physiology and efferent projections
from those neurones to secondary energy homeostatic
neurones in intra- and extra-hypothalamic sites are a key
feature of energy homeostatic circuitry. In the lateral hypo-
thalamus, projections from NPY/AGRP and POMC/CART
neurones innervate neurones that express the orexigens
melanin concentrating hormone (MCH) and orexin A and
B (60, 61). In the paraventricular nucleus, NPY/CART and
POMC/AGRP projections innervate neurones that express
corticotropin releasing hormone and thyrotropin releasing
hormone (26, 28–31, 62). The ventromedial nucleus, dorso-
medial nucleus are additional energy homeostatic hypotha-
lamic nuclei that receive projections from the arcuate nucleus
(16, 17, 63). The periventricular nucleus also receives fibres
from the arcuate nucleus (17) and, although it has not
classically been considered an energy homeostatic nucleus,
the recent report of ghrelin cell bodies in the periventricular
nucleus challenges that classification (64). A major finding of
our study was that Asb-4 mRNA is expressed in all of these
energy homeostatic associated areas, with the conspicuous
exception of the ventromedial nucleus. In view of the
prominence of NPY/AGRP and POMC/CART neurones in
energy homeostasis, it is quite significant that Asb-4 mRNA
is differentially expressed by those neurones. We also
observed Asb-4 mRNA in the posterior hypothalamus, an
area that has not been associated with energy homeostasis.
However, the posterior hypothalamus is thought to be
involved in behavioural arousal and autonomic regulation
(65), processes that closely interface with energy homeostasis.
Supporting the existence of this interface is the observation
that core elements of the energy homeostatic network are
expressed in the posterior hypothalamus, including leptin
receptors (66), MC3R and MC4R (67, 68), MCH neurones
(69) and c-MSH and AGRP fibres (24). Orexin neurones,













Fig. 3. Dark field photomicrograph showing Asb-4 mRNA in the rostral and mid-portion of the arcuate nucleus in the fed and fasted rat; Asb-4 mRNA
expression is greater in the (A) rostral arcuate nucleus than the (C) mid- arcuate nucleus of the fed animal. With fasting, there is a greater down-regulation of
Asb-4 mRNA in the (B) rostral arcuate nucleus than in the (D) mid-arcuate nucleus. Scale bar ¼ 500 lm.
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In the amygdala, Asb-4 mRNA is found in the MePD and
the BSTIA, which are areas that have been implicated in
feeding behaviour. Electrolytic lesioning of this area has been
shown to cause hyperphagia (70). In addition to this
functional data, neuroanatomical studies implicate the MePD
and BSTIA in feeding behaviour. Hypothalamic neurones
from feeding-related centres, such as the arcuate nucleus,
lateral hypothalamus and paraventricular nucleus, project to
the MePD and BSTIA (71, 72). Arcuate nucleus projections
to the MePD and BSTIA include those immunoreactive for
c-MSH and AGRP (24). MC4R receptors are expressed in
the MePD and BST (68). Of note, mice with diet-induced
obesity were observed to have a 40% up-regulation of MC4R
mRNA in the MePD (73). In addition, MCH receptor-1 and
MCH immunoreactive fibres are found in the posteromedial
amygdala and BST (70, 74). Posterior hypothalamus projec-
tions to the MePD and BSTIA have also been noted (69, 75).
Asb-4 was originally identified by database search using a
SOCS box consensus sequence (40). There are five major
protein families that have SOCS boxes (76). They differ in the
type of domain that is upstream of the SOCS box and include:
(i) SH2 domain proteins with a SOCS box; (ii) ankyrin repeat
proteins with a SOCS box; (iii) SPRY-domain (a domain found
in Dictyostelium discodeum dual-specificity kinase sp1A and
mammalian ryanodine receptor subtypes) proteins with a
SOCS box; (iv) WD40-repeat proteins with a SOCS box; and
(v) a family of small rar-like GTPases with a SOCS box.
Within the context of metabolic regulation, SOCS-3 is well
known. It has been shown to down-regulate leptin receptor
and insulin receptor signalling (47, 77). However, SOCS-3
belongs to the SH2 domain family of SOCS box proteins
whereas Asb-4 belongs to the ankyrin repeat family.
Asb-4 has nine ankyrin repeats N-terminal to its SOCS box.
Ankyrin repeats are loosely conserved sequences of approxi-
mately 33 amino acids (78). Each repeat is a helix-loop-helix
structure with a b-hairpin region that projects outward from
the helices at a 90 angle. Ankyrin repeat domains are thought
to be the site of specific protein–protein interaction.
To date, 18 Asb proteins have been isolated (76). Several
Asb proteins have been identified within the setting of a
(A)
(C)
Fed NPY Fast NPY
(B)
(D)
Fed POMC Fast POMC
Fig. 4. Photomicrographs of double in situ hybridisations demonstrating colocalisation of Asb-4 mRNA with pro-opiomelanocortin (POMC) (A,B) and
neuropeptide Y (NPY) (C,D) neurones. Blue represents digoxigenin labelled POMC and NPY neurones. Silver grains indicate Asb-4 mRNA. Arrows indicate
POMC or NPY neurones where colocalisation of Asb-4 mRNA is observed. Scale bar ¼ 50 lm.
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physiological process, but no commonality is obvious (79–
81). An Asb-1 null mouse was generated, but was not
informative with respect to to the function of Asb-1 or the
Asb protein family as a whole (82). Recently, Asb-6 was
identified as an adipocyte-specific protein that modulates APS
interaction with the insulin receptor (83).
Asb-4 is an imprinted gene on human chromosome
7q21–22 (84). Two isoforms are entered in GenBank. Isoform
b has a shorter and distinct C-terminus, which lacks the
SOCS box domain. This implies a functional difference
between isoforms. Two isoforms have not been documented
in the rat. In our study, only the long form was observed in
the arcuate nucleus.
It has been suggested that all SOCS box proteins have two
functional domains. The first is a domain upstream from the
SOCS box where unique protein–protein interactions occur.
The second is a SOCS box domain, which serves as a generic
adapter site for the elongin BC components of the E3
ubiquitin ligase complex (76). Members of the SOCS, rar,
WD-40 repeat and ankyrin repeat families of SOCS proteins
are capable of binding elongin BC in vitro (85). Within the
Asb family, Asb-1, -2, -6 and -8 have been examined and are
capable of binding elongin BC in vitro (83, 85–87). Further-
more, examination of the Asb-4 protein sequence indicates it
has the consensus elongin BC binding sequence
(T,S,P)LXXX(C,S)XXX(L,I,V) in the N-terminal part of its
SOCS box. If Asb-4 conforms to these conventions, it would
be predicted that its ankyrin repeat domain binds a specific
epitope expressed by a single target protein or class of
proteins and that its SOCS box domain regulates proteasomal
degradation (76, 88).
In summary, we have used oligonucleotide arrays to
identify 321 candidate arcuate nucleus energy homeostatic
genes. This list and the inclusive list of genes expressed in the
arcuate nucleus are a rich source of data for future studies.
We have identified Asb-4 as a gene whose mRNA is down-
regulated in the fasted and fa/fa rat and whose expression is
restricted to energy homeostasis-related brain centres. Two
neuronal types, POMC and NPY, which are critical sensors
of peripheral caloric status differentially express Asb-4
mRNA. Taken together, we hypothesise that Asb-4 encodes
an intracellular regulatory protein within CNS energy home-
ostatic circuits. Identification of proteins that bind Asb-4 and
demonstration of homeostatic changes induced by manipu-
lation of Asb-4 mRNA expression will further elucidate the
function of this transcript.
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30 Mihály E, Fekete C, Lechan RM, Liposits Z. Corticotropin-releas-
ing hormone-synthesizing neurons of the human hypothalamus re-
ceive neuropeptide Y-immunoreactive innervation from neurons
residing primarily outside the infundibular nucleus. J Comp Neurol
2002; 446: 235–243.
31 Lu XY, Barsh GS, Akil H, Watson SJ. Interaction between alpha-
melanocyte-stimulating hormone and corticotropin-releasing hor-
mone in the regulation of feeding and hypothalamo-pituitary-adre-
nal responses. J Neurosci 2003; 23: 7863–7872.
32 Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity
syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996;
274: 1704–1707.
33 Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q,
Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith
FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the mel-
anocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131–
141.
34 Yaswen L, Diehl N, Brennan MB, Hochgeschwender U. Obesity in
the mouse model of pro-opiomelanocortin deficiency responds to
peripheral melanocortin. Nature Med 1999; 5: 1066–1070.
35 Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I,
Barsh GS. Antagonism of central melanocortin receptors in vitro
and in vivo by agouti-related protein. Science 1997; 278: 135–138.
36 Fong TM, Mao C, MacNeil T, Kalyani R, Smith T, Weinberg D,
Tota MR, Van der Ploeg LH. ART (protein product of agouti-
related transcript) as an antagonist of MC-3 and MC-4 receptors.
Biochem Biophys Res Commun 1997; 237: 629–631.
37 Rosenfeld RD, Zeni L, Welcher AA, Narhi LO, Hale C, Marasco
J, Delaney J, Gleason T, Philo JS, Katta V, Hui J, Baumgartner
J, Graham M, Stark KL, Karbon W. Biochemical, biophysical,
and pharmacological characterization of bacterially expressed hu-
man agouti-related protein. Biochemistry 1998; 37: 16041–16052.
38 Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter
MA, Dekoning J, Baetscher M, Cone RD. A unique metabolic
syndrome causes obesity in the melanocortin-3 receptor-deficient
mouse. Endocrinology 2000; 141: 3518–3521.
39 Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XMYuH,
Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack
AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J,
Gopal-Truter S, MacIntyre DE, Chen HY, Van der Ploeg LH.
Inactivation of the mouse melanocortin-3 receptor results in in-
creased fat mass and reduced lean body mass. Nature Genet 2000;
26: 97–102.
40 Kile BT, Viney EM, Willson TA, Brodnicki TC, Cancilla MR,
Herlihy AS, Croker BA, Baca M, Nicola NA, Hilton DJ, Alexander
WS. Cloning and characterization of the gene encoding the ankyrin
repeat and SOCS box-containing proteins Asb-1, Asb-2, Asb-3 and
Asb-4. Gene 2000; 258: 31–41.
41 Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 4th
edn. New York: Academic Press, 1998: 26–34.
42 Schafer MKH, Herman JP, Watson SJ. In situ hybridization histo-
chemistry. In: London E, ed. Imaging Drug Action in the Brain. Boca
Raton: CRC Press, 1993: 337–378.
43 Richardson HN, Parfitt DB, Thompson RC, Sisk CL. Redefining
gonadotropin-releasing hormone (GnRH) cell groups in the male
Syrian hamster: testosterone regulates GnRH mRNA in the tenia
tecta. J Neuroendocrinol 2002; 14: 375–383.
44 Sambrook J, Fritsch EF, Maniatis T, eds. Molecular Cloning: A
Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring
Harbor Laboratory, 1989: 10.29–10.33.
45 Hammerle K, Shayan P, Niemeyer CM, Flotho C. Expression
analysis of alpha-NAC and ANX2 in juvenile myelomonocytic le-
ukemia using SMART polymerase chain reaction and virtual Nor-
thern hybridization. Cancer Genet Cytogenet 2003; 142: 149–152.
46 Li JY, Lescure PA, Misek DE, Lai YM, Chai BX, Kuick R,
Thompson RC, Demo RM, Kurnit DM, Michailidis G, Hanash SM,
Gantz I. Food deprivation-induced expression of minoxidil sulfo-
transferase in the hypothalamus uncovered by microarray analysis.
J Biol Chem 2002; 277: 9069–9076.
47 Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff
BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ,
Hastrup S. Hypothalamic CART is a new anorectic peptide regu-
lated by leptin. Nature 1998; 393: 72–76.
48 Bjorbaek C, El-Haschimi K, Frantz JD, Flier JS. The role of SOCS-
3 in leptin signaling and leptin resistance. J Biol Chem 1999; 274:
30059–30065.
49 Bates SH, Stearns WH, Dundon TA, Schubert M, Tso AW, Wang
Y, Banks AS, Lavery HJ, Haq AK, Maratos-Flier E, Neel BG,
Schwartz MW, Myers MG Jr. STAT3 signalling is required for
leptin regulation of energy balance but not reproduction. Nature
2003; 421: 856–859.
50 Niswender KD, Morrison CD, Clegg DJ, Olson R, Baskin DG,
Myers MG Jr, Seeley RJ, Schwartz MW. Insulin activation of
phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a
key mediator of insulin-induced anorexia. Diabetes 2003; 52: 227–
231.
51 Lauterio TJ, Marson L, Daughaday WH, Baile CA. Evidence for the
role of insulin-like growth factor II (IGF-II) in the control of food
intake. Physiol Behav 1987; 40: 755–758.
52 Merali Z, McIntosh J, Anisman H. Role of bombesin-related pep-
tides in the control of food intake. Neuropeptides 1999; 33: 376–386.
53 Remaury A, Vita N, Gendreau S, Jung M, Arnone M, Poncelet M,
Culouscou JM, Le Fur G, Soubrie P, Caput D, Shire D, Kopf M,
Ferrara P. Targeted inactivation of the neurotensin type 1 receptor
reveals its role in body temperature control and feeding behavior but
not in analgesia. Brain Res 2002; 953: 63–72.
54 Compere V, Li S, Leprince J, Tonon MC, Vaudry H, Pelletier G.
Effect of intra-cerebro-ventricular administration of the octadeca-
neuropeptide on the expression of pro-opiomelanocortin, neuro-
peptide Y and corticotropin-releasing hormone mRNAs in rat
hypothalamus. J Neuroendocrinol 2003; 15: 197–203.
55 Bruno JF, Olchovsky D, White JD, Leidy JW, Song J, Berelowitz M.
Influence of food deprivation in the rat on hypothalamic expression
of growth hormone-releasing factor and somatostatin. Endocrinol-
ogy 1990; 127: 2111–2116.
56 Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L.
Central administration of oleic acid inhibits glucose production and
food intake. Diabetes 2002; 51: 271–275.
57 Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W,
Soukas AA, Sharma R, Hudgins LC, Ntambi JM, Friedman JM.
Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss.
Science 2002; 297: 240–243.
58 Hertzel AV, Bernlohr DA. The mammalian fatty acid-binding pro-
tein multigene family: molecular and genetic insights into function.
Trends Endocrinol Metab 2000; 11: 175–180.
59 Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu
J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, Kahn BB.
Arcuate nucleus transcriptome profiling 403
 2005 Blackwell Publishing Ltd, Journal of Neuroendocrinology, 17, 394–404
AMP-kinase regulates food intake by responding to hormonal and
nutrient signals in the hypothalamus. Nature 2004; 428: 569–574.
60 Broberger C, De Lecea L, Sutcliffe JG, Hokfelt T. Hypocretin/or-
exin- and melanin-concentrating hormone-expressing cells form
distinct populations in the rodent lateral hypothalamus: relationship
to the neuropeptide Y and agouti gene-related protein systems.
J Comp Neurol 1998; 402: 460–474.
61 Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J,
Tatro JB, Hoffman GE, Ollmann MM, Barsh GS, Sakurai T,
Yanagisawa M, Elmquist JK. Chemically defined projections linking
the mediobasal hypothalamus and the lateral hypothalamic area.
J Comp Neurol 1998; 402: 442–459.
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